Inicio › Cáncer de pulmón › Utah
Ensayos clínicos de Cáncer de pulmón en Utah
25 estudios sobre Cáncer de pulmón buscan participantes en Utah.
Ciudades en Utah
Texto oficial del estudio (inglés)
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
- Utah Cancer Specialists, Salt Lake City
- Huntsman Cancer Institute, Salt Lake City
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT06881784SPARC - Screening for Lung Cancer With Platelets Via an AI-enabled RNA-based Classifier
- University of Utah, Salt Lake City
- Veterans Affairs SLC Health Care System (VAMC), Salt Lake City
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 21 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT07460440Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Huntsman Cancer Institute, University of Utah, Salt Lake City
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT07222566A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
- Huntsman Cancer Institute ( Site 0042), Salt Lake City
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06312137A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
- Huntsman Cancer Institute, Salt Lake City
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 sept 2026 · NCT07063745Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
- Utah Cancer Specialists, Salt Lake City
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT06712316A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
- START Mountain Region, West Valley City
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 sept 2026 · NCT06400472AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
- Avenzo Therapeutics Recruiting Site, West Valley City
ReclutandoFase 1/2
Edades de 18 a 75 · Todos los sexos · Actualizado el 4 sept 2026 · NCT07038343Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
- Huntsman Cancer Institute, Salt Lake City
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 sept 2026 · NCT06343402Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
- Huntsman Cancer Institute/University of Utah, Salt Lake City
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 ago 2026 · NCT06500481Digital Health Implementation Strategies to Improve Lung Cancer Screening Among Safety-Net Clinics
- Huntsman Cancer Institute/ University of Utah, Salt Lake City
ReclutandoSe aceptan voluntarios sanos
Edades de 50 a 80 · Todos los sexos · Actualizado el 21 jul 2026 · NCT07716280A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
- Huntsman Cancer Institute, University of Utah, Salt Lake City
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 29 jun 2026 · NCT07458347Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
- Huntsman Cancer Institute/University of Utah, Salt Lake City
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 jun 2026 · NCT05642572A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
- START Mountain Region, West Valley City
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 may 2026 · NCT07223047Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- Huntsman Cancer Institute, Salt Lake City
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 15 may 2026 · NCT05379985Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
- Huntsman Cancer Institute, University of Utah, Salt Lake City
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 14 may 2026 · NCT06922591Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
- Huntsman Cancer Institute/University of Utah, Salt Lake City
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 may 2026 · NCT06616584Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
- Huntsman Cancer Institute/University of Utah, Salt Lake City
ReclutandoFase 2
18 Minutes · Todos los sexos · Actualizado el 5 may 2026 · NCT06031688Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 abr 2026 · NCT05297734A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
- Huntsman Cancer Institute, Salt Lake City
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 abr 2026 · NCT07020221Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- University of Utah, Huntsman Cancer Institute, Salt Lake City
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 abr 2026 · NCT06810544A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
- START Mountain Region, West Valley City
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 mar 2026 · NCT06244771Improving Care for Rural Patients With Solid Tumors
- Huntsman Cancer Institute at the University of Utah, Salt Lake City
Reclutando
Edades de 18 a 99 · Todos los sexos · Actualizado el 5 feb 2026 · NCT04916990VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- Utah Cancer Specialists (site 203), Salt Lake City
ReclutandoFase 1/2
Edades de 18 a 80 · Todos los sexos · Actualizado el 11 dic 2025 · NCT03556228SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Salt Lake City
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 28 oct 2025 · NCT03452774De ClinicalTrials.gov, datos obtenidos el 1 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.